Global Carrier Screening Market Report 2023: Growing Emphasis on Early Diagnosis and Prevention of Complex Genetic Diseases Strengthens Growth

DUBLIN, July 7, 2023 /PRNewswire/ — The report “Vector Screening Market – Global Industry Size, Share, Trends, Opportunities and Forecasts, 2017-2027” has been added to ResearchAndMarkets.com offer.

The global vector screening market is anticipated to observe impressive growth during the forecast period 2023-2027.

Major factors include the increase in occurrences of genetic conditions, growing emphasis on early diagnosis and prevention, and technological developments in the field of genomics that are fueling the growth of the market. Genetic conditions are diseases caused by mutations in the normal DNA sequence.

Carrier screening is a kind of test that helps to know the risk of having a child with a genetic disease. It determines whether a healthy person contains the recessive gene of genetic diseases such as sickle cell anemia, cystic fibrosis and others.

The other factors supporting the growth of the market are the increasing investment in research and development activities by the government, the increase of numerous releases and approvals of new carrier screening tests, the increase in the birth rate in worldwide, growing attention to personalized medicine, growing population awareness of carrier screening, increasing maternal age, availability of mass genetic testing programs, and high incidence of chromosomal disorders.

Increased prevalence of genetic diseases

The increasing incidence of genetic diseases and fetal chromosomal abnormalities due to mutations in genes or chromosomes is boosting the growth of the market globally. For example, in the United States, genetic disorders are the leading cause of newborn death, accounting for nearly 20% of annual infant mortality.

Genetic diseases such as cystic fibrosis, Tay-Sachs disease and sickle cell disease occur due to inherited genetic conditions present in the parents, which can be inherited by the offspring. According to the World Health Organization (WHO), in 2019, approximately 2-5% of newborns had genetic disorders or chromosomal abnormalities. Due to the increasing occurrences of disabilities in newborns, the increased demand for prenatal testing is driving the growth of the market.

Increasing emphasis on early diagnosis and prevention of complex genetic diseases

In recent years, people have become more aware of genetic diseases, which allows them to plan and take better care of their children. The growing propensity of urban parents to delay pregnancy and the increase in the average age of mothers lead to pregnancy complications, which helps facilitate the growth of the market.

The story continues

Early diagnosis helps couples know their risk of having a child with genetic diseases or disorders early in pregnancy. Thus, the growing focus on early diagnosis and prevention of complex genetic diseases is fueling the growth of the market globally. Various initiatives are taken by governmental and non-governmental organizations for early screening of carriers. For example, in 2018, “Step One Newborn Screening” was introduced by Dubai health authority.

Technological advances fuel market growth.

The increased adoption of advanced technologies in the field of genomics is boosting market growth. Testing techniques are becoming more reliable and convenient thanks to technological advances in carrier screening methods. For example, in 2022, Thermo Fisher Scientific Inc., an American supplier of scientific products, announced the launch of a test kit based on NGS, which is a type of all-in-one carrier screening approach that helps to scan for genetic disorders, including gene expression.

Companies mentioned

• Eurofins Scientific, Inc.

• Fulgent Genetics, Inc.

• CENTOGENE NV

• Invite Corporation

• Illumina, Inc.

• Gene by Gene, Ltd.

• Laboratory Corporation of America Holdings

• natera, inc.

• Myriad Genetics, Inc.

• Quest Diagnostics, Inc.

Market segmentation

by type:

by type of screening:

by technology:

for indication:

• Cystic fibrosis

• Down syndrome

• Thalassemia

• Tay-Sachs disease

• Huntington’s disease

• Sickle cell anemia

• Others

from the end user:

• Hospitals and clinics

• Reference Laboratories

• Others

For more information about this report, please visit https://www.researchandmarkets.com/r/j47fyj

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We bring you the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

Media contact:

Research and Markets
Laura WoodChief director
press@researchandmarkets.com

For EST office hours call +1-917-300-0470
For US/CAN Call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content: https://www.prnewswire.com/news-releases/global-carrier-screening-market-report-2023-rising-emphasis-on-early-detection-and-prevention-of-complex-genetic – disorders-strengthens-growth-301871847.html

SOURCE Research and markets